SANOFI-AVENTIS, S.A. secures contract for Pharmaceutical products - 2026-171 CB Supply of drugs for the treatment of primary hypercholesterolemia (heterozygous familial and non-familial) or mixed dysplidemia with PCSK9 inhibitors

Spain, Oct. 20 -- Spain based SANOFI-AVENTIS, S.A. has secured contract from CONSORCI HOSPITAL CLINIC DE BARCELONA (HCB) for Pharmaceutical products - 2026-171 CB Supply of drugs for the treatment of primary hypercholesterolemia (heterozygous familial and non-familial) or mixed dysplidemia with PCSK9 inhibitors. The value of the contract is worth 80793 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....